Product Name :
Indacaterol
Description:
Indacaterol is an ultra-long-acting beta-adrenoceptor agonist developed by Novartis. It was approved by the European Medicines Agency (EMA) under the trade name Onbrez on November 30, 2009, and by the United States Food and Drug Administration (FDA), under the trade name Arcapta Neohaler, on July 1, 2011. It needs to be taken only once a day, unlike the related drugs formoterol and salmeterol. It is licensed only for the treatment of chronic obstructive pulmonary disease (COPD) (long-term data in patients with asthma are thus far lacking). It is delivered as an aerosol formulation through a dry powder inhaler. (Source: http://en.wikipedia.org/wiki/Indacaterol).
CAS:
312753-06-3
Molecular Weight:
392.49
Formula:
C24H28N2O3
Chemical Name:
5-[(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxy-1,2-dihydroquinolin-2-one
Smiles :
CCC1=CC2CC(CC=2C=C1CC)NC[C@H](O)C1=CC=C(O)C2NC(=O)C=CC1=2
InChiKey:
QZZUEBNBZAPZLX-QFIPXVFZSA-N
InChi :
InChI=1S/C24H28N2O3/c1-3-14-9-16-11-18(12-17(16)10-15(14)4-2)25-13-22(28)19-5-7-21(27)24-20(19)6-8-23(29)26-24/h5-10,18,22,25,27-28H,3-4,11-13H2,1-2H3,(H,26,29)/t22-/m0/s1
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥360 days if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
Indacaterol is an ultra-long-acting beta-adrenoceptor agonist developed by Novartis. It was approved by the European Medicines Agency (EMA) under the trade name Onbrez on November 30, 2009, and by the United States Food and Drug Administration (FDA), under the trade name Arcapta Neohaler, on July 1, 2011. It needs to be taken only once a day, unlike the related drugs formoterol and salmeterol. It is licensed only for the treatment of chronic obstructive pulmonary disease (COPD) (long-term data in patients with asthma are thus far lacking).{{CP-10} web|{CP-10} PROTACs|{CP-10} Biological Activity|{CP-10} Description|{CP-10} supplier|{CP-10} Epigenetics} It is delivered as an aerosol formulation through a dry powder inhaler.{{FCCP} MedChemExpress|{FCCP} PINK1/Parkin|{FCCP} Protocol|{FCCP} Data Sheet|{FCCP} manufacturer|{FCCP} Autophagy} (Source: http://en.PMID:23537004 wikipedia.org/wiki/Indacaterol).|Product information|CAS Number: 312753-06-3|Molecular Weight: 392.49|Formula: C24H28N2O3|Chemical Name: 5-[(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxy-1,2-dihydroquinolin-2-one|Smiles: CCC1=CC2CC(CC=2C=C1CC)NC[C@H](O)C1=CC=C(O)C2NC(=O)C=CC1=2|InChiKey: QZZUEBNBZAPZLX-QFIPXVFZSA-N|InChi: InChI=1S/C24H28N2O3/c1-3-14-9-16-11-18(12-17(16)10-15(14)4-2)25-13-22(28)19-5-7-21(27)24-20(19)6-8-23(29)26-24/h5-10,18,22,25,27-28H,3-4,11-13H2,1-2H3,(H,26,29)/t22-/m0/s1|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥360 days if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|Products are for research use only. Not for human use.|
